Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

HIV vaccine development.

¹Vaccine and Prevention Research, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-7628, USA. pj7p@nih.gov

Developments in Biologicals

|December 13, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Publish and Be Sued? Potential Liability for Infringement Arising through Academic Research.

Tissue engineering·2009

Same author

Progress in HIV vaccine development.

Current opinion in pharmacology·2002

Same author

Optimism is growing as researchers move toward an AIDS vaccine.

AIDS alert·2001

Same author

Season of birth in females with anorexia nervosa in Northeast Scotland.

The International journal of eating disorders·2001

Same author

Immunization. Update: search for an AIDS vaccine.

The AIDS reader·2000

Same author

The role of nonhuman primate models in AIDS vaccine development.

Molecular medicine today·2000

Same journal

Review of Ebola virus infections in domestic animals.

Developments in biologicals·2013

Same journal

Ebola: facing a new transboundary animal disease?

Developments in biologicals·2013

Same journal

Opportunities in diagnostic and vaccine approaches to mitigate potential heartwater spreading and impact on the American mainland.

Developments in biologicals·2013

Same journal

Q fever diagnosis and control in domestic ruminants.

Developments in biologicals·2013

Same journal

Schmallenberg virus.

Developments in biologicals·2013

Same journal

Classical swine fever.

Developments in biologicals·2013

See all related articles

Developing a safe and effective HIV vaccine faces scientific and logistical hurdles. Key challenges include inducing broadly neutralizing antibodies and ensuring equitable global access to future vaccines.

Area of Science:

Vaccinology
Immunology
Public Health

Background:

Significant progress has been made in expanding the HIV vaccine development pipeline.
Efforts include incorporating diverse HIV subtypes into vaccine candidates.

Purpose of the Study:

To review the current state of HIV vaccine development.
To identify remaining scientific and logistical challenges.
To discuss strategies for ensuring global access to potential HIV vaccines.

Main Methods:

Review of current HIV vaccine research and development landscape.
Analysis of scientific and logistical obstacles.
Consideration of public health and policy implications.

Main Results:

Related Experiment Videos

No current vaccine candidate elicits broadly neutralizing antibodies.
The precise immune responses needed for protection are not yet defined.
Vaccine efficacy may focus on viral control rather than complete prevention.

Conclusions:

While optimism for an effective HIV vaccine exists, substantial scientific challenges remain.
Logistical hurdles, including manufacturing, distribution, and regulatory capacity, must be overcome.
Ensuring equitable access to future HIV vaccines is a critical consideration.